Process of making derivatives of substituted morpholines
US-2026078098-A1 · Mar 19, 2026 · US
Supernus Pharmaceuticals Inc holds 127 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 127 |
| Recent patents | 29 |
| First publication | Jan 15, 2015 |
| Latest publication | Mar 19, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026078098-A1 · Mar 19, 2026 · US
US-12569471-B2 · Mar 10, 2026 · US
US-2026028340-A1 · Jan 29, 2026 · US
US-2026008759-A1 · Jan 8, 2026 · US
US-2025367208-A1 · Dec 4, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026078098-A1 · Mar 19, 2026 · US
US-12569471-B2 · Mar 10, 2026 · US
US-2026028340-A1 · Jan 29, 2026 · US
US-2026008759-A1 · Jan 8, 2026 · US
US-2025367208-A1 · Dec 4, 2025 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P25/00 | 76 |
| A61P25/24 | 49 |
| A61K9/2054 | 42 |
| A61P25/20 | 35 |
| A61K9/2013 | 33 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 112 |
| Chemistry & Metallurgy | 37 |
| Operations & Transport | 14 |
| Cross-Sectional Technologies | 10 |
| Physics | 3 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.